White matter hyperintensities and imaging patterns of brain ageing in the general population

Brain

Volumn 139, Issue 4, 2016, Pages 1164-1179

  Habes, Mohamad ^a,b   Erus, Guray ^b   Toledo, Jon B ^c   Zhang, Tianhao ^b   Bryan, Nick ^b   Launer, Lenore J ^d   Rosseel, Yves ^e   Janowitz, Deborah ^a   Doshi, Jimit ^b   Van Der Auwera, Sandra ^a,f   Von Sarnowski, Bettina ^a   Hegenscheid, Katrin ^a   Hosten, Norbert ^a   Homuth, Georg ^a   Völzke, Henry ^a   Schminke, Ulf ^a   Hoffmann, Wolfgang ^a,f   Grabe, Hans J ^a,f   Davatzikos, Christos ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e GHENT UNIVERSITY   (Belgium)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease; brain ageing; cardiovascular disease; mild cognitive impairment; white matter hyperintensities

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; ARTICLE; BLOOD PRESSURE MONITOR; BRAIN ATROPHY; BRAIN REGION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATION; FEMALE; FRAMINGHAM RISK SCORE; GENE; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEARNING AND MEMORY TEST; LIPOPROTEIN BLOOD LEVEL; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECALL; SMOKING; STRUCTURAL EQUATION MODELING; VERBAL MEMORY TEST; VERY ELDERLY; WHITE MATTER; WHITE MATTER HYPERINTENSITY; BRAIN; COGNITION DISORDERS; COHORT ANALYSIS; DEMENTIA; GERMANY; HEALTH SURVEY; PATHOLOGY; POLAND; PROCEDURES; RISK FACTOR; TRENDS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLAND; POPULATION SURVEILLANCE; RISK FACTORS; WHITE MATTER; YOUNG ADULT;

EID: 84964413922     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww008     Document Type: Article

References (88)

1. Appel J, Potter E, Bhatia N, Shen Q, Zhao W, Greig MT, et al. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. Am J Neuroradiol 2009; 30: 1870-6.
2. Aribisala B, Valdés Hernández M, Royle N, Morris Z, Muñoz Maniega S, Bastin M, et al. Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936. Eur. Radiol 2013; 23: 1084-92.
3. Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging 2015; 36: 27-32.
4. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, et al. Longitudinal changes in white matter disease and cognition in the first year of the alzheimer disease neuroimaging initiative. Arch Neurol 2010; 67: 1370-8.
5. Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, et al. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 2009; 72: 125-34.
6. Crane DE, Black SE, Ganda A, Mikulis DJ, Nestor SM, Donahue MJ, et al. Gray matter blood flow and volume are reduced in association with white matter hyperintensity lesion burden: a cross-sectional MRI study. Front Aging Neurosci 2015; 7: 131.
7. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation 2008; 117: 743-53.
8. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008; 39: 349-54.
9. Davatzikos C, Genc A, Xu D, Resnick SM. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage 2001; 14: 1361-9.
10. Davatzikos C, Xu F, An Y, Fan Y, Resnick SM. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 2009; 132: 2026-35.
11. Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, et al. Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. Neuroimage Clin 2014; 4: 164-73.
12. Debette S, Seshadri S, Beiser A, Au R, Himali J, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77: 461-8.
13. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, Deep WMH, and total WMH burden. Stroke 2005; 36: 50-5.
14. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007; 64: 108-15.
15. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloidpositive individuals. Cereb Cortex 2009; 19: 497-510.
16. Doshi J, Erus G, Ou Y, Gaonkar B, Davatzikos C. Multi-atlas skullstripping. Acad Radiol 2013; 20: 1566-76.
17. Draganski B, Ashburner J, Hutton C, Kherif F, Frackowiak RSJ, Helms G, et al. Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). Neuroimage 2011; 55: 1423-34.
18. Du A-T, Schuff N, Chao LL, Kornak J, Ezekiel F, JagustWJ, et al.White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005; 26: 553-9.
19. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001; 56: 921-6.
20. Duval C, Bejanin A, Piolino P, Laisney M, de La Sayette V, Belliard S, et al. Theory of mind impairments in patients with semantic dementia. Brain J Neurol 2012; 135: 228-41.
21. Erten-Lyons D, Woltjer R, Kaye J, Mattek N, Dodge HH, Green S, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 2013; 81: 977-83.
22. Erus G, Battapady H, Zhang T, Lovato J, Miller ME, Williamson JD, et al. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care 2014; 38: 97-9104.
23. Fan Y, Batmanghelich N, Clark CM, Davatzikos C, Alzheimer's Disease Neuroimaging Initiative. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008; 39: 1731-43.
24. Fan Y, Shen D, Gur RC, Gur RE, Davatzikos C. COMPARE: classification of morphological patterns using adaptive regional elements. IEEE Trans Med Imaging 2007; 26: 93-105.
25. Fleischmann UM, Oswald WD. Nü rnberger-Alters-Inventar: (NAI): Testmanual und Textband. Gö ttingen, Germany: Hogrefe, Verlag fü r Psychologie. 1999.
26. Franke K, Gaser C, Manor B, Novak V. Advanced brainAGE in older adults with type 2 diabetes mellitus [Internet]. Front Aging Neurosci 2012; 5: 90. Available from: http://dx.doi.org/10.3389/fnagi.2013. 00090
27. Franke K, Ziegler G, Klö ppel S, Gaser C. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters. Neuroimage 2010; 50: 883-92.
28. Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010; 6: 67-77.
29. Gardener H, Wright CB, Rundek T, Sacco RL. Brain health and shared risk factors for dementia and stroke. Nat Rev Neurol 2015; 11: 651-7.
30. Gaser C, Franke K, Klö ppel S, Koutsouleris N, Sauer H, Initiative ADN. BrainAGE in mild cognitive impaired patients: predicting the conversion to Alzheimer's disease. PLoS One 2013; 8: e67346
31. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002; 17: 29-46.
32. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672-713.
33. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82: 126-35.
34. Grueter BE, Schulz UG. Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad Med J 2012; 88: 79-87.
35. Habes M, Schiller T, Rosenberg C, Burchardt M, Hoffmann W. Automated prostate segmentation in whole-body MRI scans for epidemiological studies. Phys Med Biol 2013; 58: 5899
36. Hegenscheid K, Kühn JP, Vö lzke H, Biffar R, Hosten N, Puls R. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. RöFo 2009; 181: 748-59.
37. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (Berl) 2010; 119: 579-89.
38. Jack CRJ, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, et al. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings. Brain J Neurol 2015; 138: 3447-59.
39. Jagust W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 2013; 77: 219-34.
40. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke 2004; 35: 1857-61.
41. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JPW, et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 2007; 50: 1509-16.
42. Kievit RA, Davis SW, Mitchell DJ, Taylor JR, Duncan J, Cam-CAN Research Team, et al. Distinct aspects of frontal lobe structure mediate age-related differences in fluid intelligence and multitasking [Internet]. Nat Commun 2014; 5: 5658. Available from: http://dx. doi.org/10.1038/ncomms6658
43. Klö ppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, et al. Automatic classification of MR scans in Alzheimer's disease. Brain 2008; 131: 681-9.
44. Kubicki M, Westin C-F, Maier SE, Frumin M, Nestor PG, Salisbury DF, et al. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry 2002; 159: 813-20.
45. Lao Z, Shen D, Liu D, Jawad AF, Melhem ER, Launer LJ, et al. Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol 2008; 15: 300-13.
46. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10: 969-77.
47. Li C, Gore JC, Davatzikos C. Multiplicative intrinsic component optimization (MICO) for MRI bias field estimation and tissue segmentation. Magn Reson Imaging 2014; 32: 913-23.
48. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study. Stroke 1996; 27: 1274-82.
49. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013; 36: 4036-42.
50. Ou Y, Sotiras A, Paragios N, Davatzikos C. DRAMMS: deformable registration via attribute matching and mutual-saliency weighting. Spec Sect 2011; 15: 622-39.
51. Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala E-L, Hanninen T, et al. A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005; 76: 11-4.
52. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 2005; 57: 98-103.
53. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 2015; 11: 157-65.
54. Rachael IS, Chris F, Rhian J, Jennifer LW, Martin NR, Nick CF. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989-94.
55. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Longstreth WTJ, Gach HM, et al. White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2012; 33
56. Raz N, Ghisletta P, Rodrigue KM, Kennedy KM, Lindenberger U. Trajectories of brain aging in middle-aged and older adults: regional and individual differences. Neuroimage 2010; 51: 501-11.
57. Raz N, Lindenberger U, Ghisletta P, Rodrigue KM, Kennedy KM, Acker JD. Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cereb Cortex 2008; 18: 718-26.
58. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 2003; 23: 3295-301.
59. Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw 2012; 48: 1-36.
60. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58: 610-6.
61. Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 2007; 33: 410-9.
62. Smith EE, O'Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, et al. Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol 2015; 77: 251-61.
63. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, et al. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 2006; 66: 1476-84.
64. Team RDC. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available from: http://www.R-project.org
65. Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain 2013; 136: 2697-706.
66. Toledo JB, Bjerke M, Chen M, Royzycki M, Jack CR, Weiner MW, et al. Memory, executive and multi-domain subtle cognitive impairment: clinical and biomarker findings. Neurology 2015; 85: 144-53.
67. Toledo J, Weiner M, Wolk D, Da X, Chen K, Arnold S, et al. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun 2014; 2: 26
68. Tuladhar AM, Reid AT, Shumskaya E, de Laat KF, van Norden AGW, van Dijk EJ, et al. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke J Cereb Circ 2015; 46: 425-32.
69. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004; 63: 246-53.
70. Tustison NJ, Avants BB, Cook P, Zheng Y, Egan A, Yushkevich P, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 2010; 29: 1310-20.
71. Van der Flier WM, van Straaten ECW, Barkhof F, Ferro JM, Pantoni L, Basile AM, et al. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in nondisabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 2005; 76: 1497-500.
72. Vapnik V. The nature of statistical learning theory (Information Science and Statistics), 2nd ed. Berlin, Germany: Springer Science & Business Media; 1999.
73. Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, et al. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 2008; 39: 1186-97.
74. Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, Przybelski SA, et al. Antemortem differential diagnosis of dementia pathology using structural MRI: differential-STAND. Neuroimage 2011; 55: 522-31.
75. Verhaaren BFJ, Debette S, Bis JC, Smith JA, Ikram MK, Adams HH, et al. Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI [Internet]. Circ Cardiovasc Genet 2015; 8: 398-406. Available from: http://circgenetics.ahajournals. org/content/early/2015/02/07/CIRCGENETICS.114.000858.abstract
76. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
77. Vö lzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in pomerania [Internet]. Int J Epidemiol 2011; 40: 294-307. Available from: http://ije.oxford journals.org/content/early/2010/02/18/ije.dyp394.short
78. Wang R, Fratiglioni L, Laveskog A, Kalpouzos G, Ehrenkrona C-H, Zhang Y, et al. Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study. Eur J Neurol 2014; 21: 1076-82.
79. Wang W-Y, Yu J-T, Liu Y, Yin R-H, Wang H-F, Wang J, et al. Voxelbased meta-analysis of grey matter changes in Alzheimer's disease. Transl Neurodegener 2015; 4: 6.
80. Wardlaw JM, Allerhand M, Doubal FN, Valdes Hernandez M, Morris Z, Gow AJ, et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 2014; 82: 1331-8.
81. Wardlaw JM, Pantoni L. Sporadic small vessel disease: pathogenic aspects [Internet]. In: Cerebral Small Vessel Disease. Cambridge: Cambridge University Press; 2014. p. 52. Available from: http:// dx.doi.org/10.1017/CBO9781139382694.007
82. Wardlaw JM, Valdés Hernández MC, MuñozManiega S. What are White matter hyperintensities made of? Relevance to vascular cognitive impairment [Internet]. J Am Heart Assoc 2015; 4: 001140. Available from: http://jaha.ahajournals.org/content/4/6/ 001140.short
83. Wardlaw J, Smith C, Dichgans M. Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 10-1016/S1474-4422(13)70060-7.
84. Wen W, Sachdev PS, Chen X, Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006; 29: 1031-9.
85. Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, et al. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol 2013; 70: 1512-9.
86. Woods SP, Delis DC, Scott JC, Kramer JH, Holdnack JA. The California Verbal Learning Test-second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch Clin Neuropsychol 2006; 21: 413-20.
87. Zhang T, Davatzikos C. ODVBA: optimally-discriminative voxelbased analysis. IEEE Trans Med Imaging 2011; 30: 1441-54.
88. Zhang T, Davatzikos C. Optimally-discriminative voxel-based morphometry significantly increases the ability to detect group differences in schizophrenia, mild cognitive impairment, and Alzheimer's disease. Neuroimage 2013; 79: 94-110.